Activa Capital has acquired a majority position in Medisys, together with Turenne Santé, the entrepreneur
and new CEO Guillaume Bouillot and the management team. Bernard Chevalier, founder, is supporting the
operation and remains a shareholder.
Medisys is a leading software publisher in the home-care field and for institutions specialized in dependent
After nearly 30 years at the head of the company based in Aix-en-Provence and created in 1991, its founder
Bernard Chevalier hands over the management to Guillaume Bouillot, a software entrepreneur.
The new management team will build on values that have made the company successful while providing
the means to accelerate the digitalization of personal services. The challenge is to support the
transformation of organizations that bring together care institutions, home support, medical/nursing
services and aids to daily life. Medisys’ development is based on its recognized expertise in the care of
dependent persons and on its technological innovations making it possible to streamline the operators’
organization and secure the patient follow-up. The company also intends to intensify the deployment of
traceability systems for hygiene and cleaning services in sensitive environments, particularly in the medical
sector, with its Mobiserv solution.
Thanks to 17 years of experience between the creation and sale of Eudonet (a publisher of CRM solutions),
Guillaume Bouillot brings a new energy to the company with a desire to accelerate by fostering links with
customers and the ecosystem.
Activa Capital and Turenne Santé will enable Medisys to strengthen its positions through strategic
acquisitions to complete its offer.
With this transaction, Activa Capital is making the 9th investment of its latest fund, Activa Capital Fund III.
Guillaume Bouillot, President of Medisys Holding, said: “I was very impressed by Activa Capital’s unique
ability to support entrepreneurs and bring its skills and energy to bear on their ambitions. The association
with the sector specialist Turenne Santé is a key asset for this transition from one entrepreneur to another
in a consolidating sector”.
Bernard Chevalier, Founder of Medisys, added: “This is a new momentum for Medisys, which has the solid
fundamentals to pursue and expand its rapid development and satisfy our most demanding clients in the
Christophe Parier and Alexandre Masson, Partners of Activa Capital, completed: “We were impressed by
Medisys’ history and positioning. The arrival of Guillaume Bouillot will enable the company to carry out its
ambitious development projects. This acquisition is in line with Activa Capital’s strategy of investing in
companies that are at a turning point in their growth to help them accelerate their development”.
Mounia Chaoui, Associate Director, Turenne Santé stated: “We are delighted to support Guillaume Bouillot
and the Medisys teams in the takeover of the group, in partnership with Activa Capital. Medisys has
developed a remarkable offer that facilitates the development of home services, at the heart of new
healthcare policies that we are addressing with Capital Santé 2”.
Corporate lawyer: Allen Overy (Raphaël Bloch)
Activa Capital: Christophe Parier, Alexandre Masson, Frédéric Singer, Elliot Thiéblin
Turenne Santé: Mounia Chaoui, Grégory Dupas
Financial Due Diligence: PwC (David Willems, Pierre-Mikhaël, Kévin Barrier)
Strategic Due Diligence: PMSI (Remi de Guilhermier, Florence Royer, Lucinda Nicholson)
Social and legal Due Diligence: Hogan Lovells (Stéphane Huten, Paul Leroy, Alexandre Jeannerot)
M&A advisor: Bryan Garnier (Thibaut De Smedt, Pierre Lafitte, Alexandre Brestin)
Corporate lawyers: Hogan Lovells (Stéphane Huten, Paul Leroy, Alexandre Jeannerot), Paul Hastings
Financing lawyer: Hogan Lovells (Alexander Premont, Luc Bontoux, Adrien Gaudron)
Vendor Due Diligence: Exelmans (Stéphane Dahan, Manuel Manas, Matthieu Réglade, Philippe Pelet)
M&A advisor: Edmond de Rothschild Corporate Finance (Philippe Duval, Marguerite Mell, Lucrèce
d’Assignies, Aurélien Rivière)
Corporate lawyer: Lamartine Conseil (Vincent Libaud)
Senior debt: Crédit du Nord (Bertrand Descours, Amandine Proux), Crédit Agricole Provence Alpes Côte
d’Azur (Christophe Lejeune, Violaine Mahier), BNP Paribas (Mathias Ronzeaud)
About Activa Capital
Activa Capital is an independent private equity company, owned by its partners, characterized by a proactive
strategy of supporting growth (organic and external). It currently manages more than €500 million on behalf
of institutional investors by investing in French SMEs and Mid-Caps with high growth potential and an
enterprise value ranging between €20 million and €100 million. Activa Capital supports its portfolio
companies to accelerate their development and international presence, often through active build-up
To learn more about Activa Capital, visit activacapital.com
About Turenne Capital Group
With more than €220 million under management, including more than €100 million for the FPCI Capital
Santé 2, Turenne Santé supports healthcare companies in their development and transmission challenges.
As an independent private equity player in France, the Turenne Capital group manages more than €1 billion.
Its teams, composed of 55 professionals, including 38 investors, based in Paris, Lille, Lyon, Marseille and
Metz, support more than 250 companies employing more than 23,000 people in the health, hospitality,
new technology, distribution and innovative services sectors.
To learn more about Turenne Capital, visit www.turennecapital.com
Christophe Parier Alexandre Masson Christelle Piatto
Partner Partner Communications Manager
+33 1 43 12 50 12 +33 1 43 12 50 12 +33 1 43 12 50 12
firstname.lastname@example.org email@example.com firstname.lastname@example.org
Mounia Chaoui Josepha Montana
Partner Communications Manager
+33 1 53 43 03 03 +33 1 53 43 03 03